Abstract
It was the purpose of this study to investigate racial alterations in β-adrenoceptor response. Two groups of healthy, male volunteers gave their consent. There were eight black Americans (mean age, 26.1 ± 2.5 years) and eight white/Caucasian Americans (mean age, 24.4 ± 1.8 years). Each subject underwent an isoproterenol sensitivity test. There was a significant (P < 0.05) decrease in the ratio of E max to ED50 in the white group (25.3 ± 6.4) compared with the black group (37.1 ± 12.4). Over the dose range of 0.1 to 1.0 µg there was a significant increase in response at both the 0.25- and the 0.5-µg dose (P < 0.05), with the black American group appearing to respond with a greater rate of rise in heart rate following the initial doses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
K. K. Chen and E. J. Poth. J. Pharmacol. Exp Ther. 36:429 (1929).
T. G. Scott. Br. J. Ophthalmol. 29:12 (1945).
Hypertension Detection and Follow-up Program Cooperative Group. Am. J. Epidemiol. 106:351–361 (1977).
T. Gordon and B. Devin. Hypertension and Hypertensive Heart Disease in Adults: United States. 1960–1962, DHEW Publ. No. (PHS) 1000, U.S. Government Printing Office, Washington, D.C. 1966 (Vital and Health Statistics Ser. 11, No. 13).
J. Roberts and K. Maurer. Blood Pressure Levels of Persons 6–74 Years, DHEW Publ. No. (HRA) 78-1648, U.S. Government Printing Office, Washington, D.C., 1977 (Vital and Health Statistics Ser. 11, No. 203).
J. Roberts and M. Rowland. Hypertension in Adults 25–74 Years of Age: United States, 1971–1975, DHHS Publ. No. (PHS) 81-1671, U.S. Government Printing Office, Washington, D.C. 1981 (Vital and Health Statistics Ser. 11, No. 221).
J. Stamler, R. Stamler, W. F. Riedlinger, G. Algera, and R. H. Roberts. Hypertension screening of one million Americans: Community Hypertension Evaluation Clinic (CHEC) Program. 1973 through 1975. JAMA 235:2299–2306 (1976).
Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension 7:457–468 (1985).
Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA 248:1996–2003 (1982).
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Am. J. Cardiol. 52:1230–1237 (1983).
Y. K. Seedat. Br. Med. J. 281:1241–1243 (1980).
M. Moser and J. Lunn. Angiology 32:561–566 (1981).
R. J. Glassock, R. E. Weitzman, C. M. Bennett, M. Maxwell, B. Hamilton, N. Winer, W. Kirkendall, and L. Gonasum. Am. Heart J. 104:421–425 (1982).
W. H. Frishman. N. Engl. J. Med. 305:678–682 (1981).
W. Frishman and R. Silverman. Am. Heart J. 97:797–807 (1979).
R. E. Vestal, A. J. J. Wood, and D. G. Shand. Clin. Pharmacol. Ther. 26:181–186 (1979).
C. R. Cleveland, R. E. Rangno, and D. G. Shand. Arch. Intern. Med. 130:47–51 (1972).
G. M. London, M. E. Safar, Y. A. Weiss, and P. L. Milliez. J. Clin. Pharmacol. April:174–182 (1976).
G. Eisenhofer, D. G. Lambie, and R. H. Johnson. Br. J. Clin. Pharmacol. 20:684–687 (1985).
T. H. Pringle, P. C. O'Connor, A. J. McNeill, M. B. Finch, J. G. Riddell, and K. G. Shanks. Br. J. Clin. Pharmacol. 21:249–258 (1986).
N. H. G. Holford and L. B. Sheiner. Clin. Pharmacokin. 6:429–453 (1981).
N. H. G. Holford and L. B. Sheiner. CRC Crit. Rev. Bioeng. 5:273–322 (1981).
K. Yamaoka, T. Nakagawa, and T. Uno. J. Pharmacokinet. Biopharm. 6:165–175 (1978).
J. M. O. Arnold and D. G. McDevitt. Br. J. Clin. Pharmacol. 15:423–429 (1983).
J. M. O. Arnold and D. G. McDevitt. Br. J. Clin. Pharmacol. 18:311–316 (1984).
M. Stein, S. Kilfeather, and K. O'Malley. Br. J. Clin. Pharmacol. 24:251P–252P (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rutledge, D.R., Cardozo, L. & Steinberg, J.D. Racial Differences in Drug Response: Isoproterenol Effects on Heart Rate in Healthy Males. Pharm Res 6, 182–185 (1989). https://doi.org/10.1023/A:1015996929574
Issue Date:
DOI: https://doi.org/10.1023/A:1015996929574